Mustafa Vakur Bor1, Ebba Nexø, Anne-Mette Hvas. 1. Department of Clinical Biochemistry, AKH, Aarhus University Hospital, Norrebrogade 44, DK-8000 Aarhus C, Denmark. vakurbor@hotmail.com
Abstract
BACKGROUND: We evaluated whether measurement of vitamin B(12)-saturated transcobalamin (holo-TC) concentrations or TC saturation (holo-TC:total TC) reflects active vitamin B(12) absorption in healthy individuals and patients after vitamin B(12) intake. METHODS: We obtained blood samples from 31 healthy individuals (age range, 25-57 years) before (days -1 and 0) and after (days 1, 2, and 6) oral administration of three 9-microg doses of vitamin B(12). The blood samples from seven patients (age range, 22-39 years) suspected to have decreased vitamin B(12) absorption were obtained before and 1 day after the vitamin B(12) intake. The blood samples were analyzed for vitamin B(12), total TC, and holo-TC. The TC saturation was calculated. RESULTS: Intraindividual variation was <13% for all measured values, as calculated from samples removed on day -1 and 0. In healthy individuals (n = 31) after intake of vitamin B(12), the maximum median (range) increase (as percentages and absolute values) was in TC saturation [52 (-2% to 128)% and 0.04 (0-0.23) as a fraction], closely followed by holo-TC concentrations [39 (0-108)% and 34 (0-149) pmol/L]. All but one healthy individual had an increase of >/=15% in these markers. Serum vitamin B(12) showed a smaller increase [14 (-8 to 51)% and 36 (-27 to 290) pmol/L]. After vitamin B(12) intake, three patients with Crohn disease had the lowest increases in holo-TC concentration (3, 7, and 14 pmol/L) and in TC saturation (0.004, 0.01, and 0.01) among patients and 30 healthy individuals. CONCLUSION: Holo-TC concentrations and TC saturation reflect normal vitamin B(12) absorption better than does serum vitamin B(12).
BACKGROUND: We evaluated whether measurement of vitamin B(12)-saturated transcobalamin (holo-TC) concentrations or TC saturation (holo-TC:total TC) reflects active vitamin B(12) absorption in healthy individuals and patients after vitamin B(12) intake. METHODS: We obtained blood samples from 31 healthy individuals (age range, 25-57 years) before (days -1 and 0) and after (days 1, 2, and 6) oral administration of three 9-microg doses of vitamin B(12). The blood samples from seven patients (age range, 22-39 years) suspected to have decreased vitamin B(12) absorption were obtained before and 1 day after the vitamin B(12) intake. The blood samples were analyzed for vitamin B(12), total TC, and holo-TC. The TC saturation was calculated. RESULTS: Intraindividual variation was <13% for all measured values, as calculated from samples removed on day -1 and 0. In healthy individuals (n = 31) after intake of vitamin B(12), the maximum median (range) increase (as percentages and absolute values) was in TC saturation [52 (-2% to 128)% and 0.04 (0-0.23) as a fraction], closely followed by holo-TC concentrations [39 (0-108)% and 34 (0-149) pmol/L]. All but one healthy individual had an increase of >/=15% in these markers. Serum vitamin B(12) showed a smaller increase [14 (-8 to 51)% and 36 (-27 to 290) pmol/L]. After vitamin B(12) intake, three patients with Crohn disease had the lowest increases in holo-TC concentration (3, 7, and 14 pmol/L) and in TC saturation (0.004, 0.01, and 0.01) among patients and 30 healthy individuals. CONCLUSION:Holo-TC concentrations and TC saturation reflect normal vitamin B(12) absorption better than does serum vitamin B(12).
Authors: Simon M Collin; Chris Metcalfe; Helga Refsum; Sarah J Lewis; Luisa Zuccolo; George Davey Smith; Lina Chen; Ross Harris; Michael Davis; Gemma Marsden; Carole Johnston; J Athene Lane; Marta Ebbing; Kaare Harald Bønaa; Ottar Nygård; Per Magne Ueland; Maria V Grau; John A Baron; Jenny L Donovan; David E Neal; Freddie C Hamdy; A David Smith; Richard M Martin Journal: Cancer Epidemiol Biomarkers Prev Date: 2010-05-25 Impact factor: 4.254
Authors: Marjorie G Garrod; Ralph Green; Lindsay H Allen; Dan M Mungas; William J Jagust; Mary N Haan; Joshua W Miller Journal: Clin Chem Date: 2008-05-01 Impact factor: 8.327
Authors: Lars Orning; Anne Rian; Andrew Campbell; Jeff Brady; Sergey N Fedosov; Birgit Bramlage; Keith Thompson; Edward V Quadros Journal: Nutr Metab (Lond) Date: 2006-01-04 Impact factor: 4.169
Authors: Dattatray S Bhat; Nileema V Thuse; Himangi G Lubree; Charudatta V Joglekar; Sadanand S Naik; Lalita V Ramdas; Carole Johnston; Helga Refsum; Caroline H Fall; Chittaranjan S Yajnik Journal: J Nutr Date: 2009-09-23 Impact factor: 4.798